Not always as dramatic as injection results, but meaningful enough to warrant the approach for patients who refuse or cannot tolerate injections
When GLP-1 therapy and movement work together, results are healthier, longer-lasting, and more empowering
For some patients, returning to or optimising conventional therapies such as metformin (if not already at maximum tolerated dose), sulphonylureas, or basal insulin may be appropriate
The enforcement grace periods ended February 18, 2025 for 503A pharmacies and March 19, 2025 for 503B outsourcing facilities
The injection speed also matters
This often leads to an increase in the consumption of iron-fortified foods, potentially contributing to iron overload in certain population groups